Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Indonesia says finds two cases of Indian COVID-19 variant in Jakarta

Published 05/03/2021, 05:06 AM
Updated 05/03/2021, 05:10 AM
© Reuters. Schools reopen amid coronavirus disease (COVID-19) outbreak in Bekasi, Indonesia

JAKARTA (Reuters) - Indonesia has recorded its first cases of a highly infectious COVID-19 variant first detected in India, the health minister said on Monday, as authorities implored people not to travel to their hometowns for the end of the Muslim fasting month.

Indonesia, which has been trying to contain one of the worst COVID-19 outbreaks in Asia, stopped issuing visas last month for foreigners who had been in India in the previous 14 days.

The two cases of the Indian variant, known as B.1.617, were found in Jakarta, while the minister said a variant first discovered in South Africa was also detected in Bali.

"We need to contain these cases, while there are still only a few of them," Budi Gunadi Sadikin told a virtual conference.

Scientists are studying whether the B.1.617 variant is to blame for India's devastating second wave of infections.

The variant has now reached at least 17 countries including Britain, Switzerland and Iran, prompting some governments to close their borders to people traveling from India.

Authorities in Indonesia, which is the world's largest Muslim-majority country, have also banned the traditional mass exodus where people visit relatives for the Eid al-Fitr festival for a second year to curb COVID-19 transmission.

"Do not return to your hometown. Do not go on holiday in your hometown. Be patient," Doni Monardo, the chief of Indonesia's COVID-19 task force, told the same news conference.

Indonesia has reported more than 1.67 million virus infections and 45,700 deaths since the start of the pandemic, though cases have been declining since peaking in January.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Nonetheless, the positivity rate, or the percentage of people tested who are found to have the disease, was still hovering at more than 12% on average last month. The World Health Organization considers positivity rates above 5% to be of concern.

Latest comments

hi
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.